Established in 2006, Genolution Inc.
has been providing solutions toward a better life
by focusing on the fields
molecular diagnostics and RNAi.
Genolution core technologies to develop faster, more affordable, and higher through-put nucleic acid extraction platforms led to the development of the Nextractor® nucleic acid extraction instrument series and extraction kits; they were vital for our progress in the fields of molecular diagnostics, genetic testing, and life sciences research
Double-stranded RNA (dsRNA) synthesis technology enabled us to equip researchers with large-scale dsRNA for gene expression studies and pest control product development.
• CEO, Hoilbiomed
• B.A. in History, Korea University
• Senior Scientist, Samsung Bioepis
• Researcher, Beth Israel Deaconess Medical Center
• Ph.D. in Molecular, Cellular Developmental Biology, Yale University
• SVP, Finance&Accounting, Kumho Asiana
• B.A. in Business Administration, Korea University/MBA in Finance, Syracuse University